Skip to Main Content

Paper Details

Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
Pharmacogenet Genomics
4
2021
CYP2A6, CYP2A6 intron, DNA, Exemestane, Germline DNA, Letrozole, aromatase, cytochrome P450 2A6, exemestane, exonic variants, germline, germline variant, hormone-receptor, hormone-receptor-positive breast cancer, identified, intronic rs56113850 variant, letrozole, non-, nonexonic variants, nonmetastatic breast cancer, patients, polymorphisms, rs56113850, rs7937
Author NameAffiliation
Kelley M KidwellUniversity of Michigan School of Public Health, University of Michigan ann arbor
Anna Maria StornioloIndiana University School of Medicine
Vered StearnsSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
  • 1 - 3

Datasets

Release 1.2